A pyrimidine–pyrazolone nucleoside chimera with potent in vitro anti-orthopoxvirus activity
- 15 June 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (12) , 3224-3228
- https://doi.org/10.1016/j.bmcl.2006.03.043
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Report Faults Smallpox VaccinationScience, 2005
- Smallpox: a disease and a weaponInternational Journal of Infectious Diseases, 2004
- The development of novel inhibitors of tumor necrosis factor-α (TNF-α) production based on substituted [5,5]-bicyclic pyrazolonesBioorganic & Medicinal Chemistry Letters, 2004
- Inhibitory Activity of Alkoxyalkyl and Alkyl Esters of Cidofovir and Cyclic Cidofovir against Orthopoxvirus Replication In VitroAntimicrobial Agents and Chemotherapy, 2004
- Development of Orally Bioavailable Bicyclic Pyrazolones as Inhibitors of Tumor Necrosis Factor-α ProductionJournal of Medicinal Chemistry, 2004
- Countering the Posteradication Threat of Smallpox and PolioClinical Infectious Diseases, 2002
- Vaccines for Biodefense: A System in DistressScience, 2001
- Synthesis of oligonucleotides containing the oxidatively modified B site: unique binding affinity to the NF B p50 homodimerNucleic Acids Symposium Series, 1999
- Oxime and dithiolane derivatives of 5-formyl-2'-deoxyuridine and their 5'-phosphates: antivirial effects and thymidylate synthetase inhibitionJournal of Medicinal Chemistry, 1980
- Synthesis of 5-substituted 2'-deoxyuridinesJournal of Medicinal Chemistry, 1976